期刊文献+

高效液相色谱法测定盐酸吡格列酮的血药浓度 被引量:3

HPLC determination of pioglitazone hydrochloride plasma concentration
下载PDF
导出
摘要 目的:建立高效液相色谱法测定人血浆中盐酸吡格列酮浓度的方法。方法:以卡马西平为内标,血浆样品用醋酸乙酯萃取,采用Diamonsil(TM)C18柱(250mm×4.6mm,5μm)分析。流动相为乙腈-0.05mol·L^-1磷酸二氢钾(pH6.5)(42:58),流速1.2mL·min^-1,检测波长229nm,柱温35℃。结果:本法在0.025~4.0mg·L^-1间线性关系良好,r=0.9999,RSD为2.08%,(n=6),最低检测质量浓度为0.02mg·L^-1。日内、日间精密度RSD均小于10%,低、中、高浓度的提取回收率均大于99%(n=5)。结论:此方法灵敏度高、重复性好,尤其适用于临床治疗合并用药时的药物浓度监测。 OBJECTIVE To establish an HPLC method to determine the concentration of pioglitazone hydrochloride in human plasma. METHODS With carbamazepine as internal standard, the plasma sample was extracted with ethylacetate. The separation was carried out using Diamonsil(TM) C18 (250 mm × 4.6 mm, 5 μm) column with mobile phase of acetonitrile-0. 05 mol·L^-1 KH2PO4 buffer solution (pH 6. 5) (42:58). The flow rate was 1.2 mLomin l The detection wave length was 229 nm. The column temperature was 35 ~C. RESULTS The linear range was 0. 025 - 4.0 mg·L^-1. The correlation coefficient was 0. 999 9 (n = 6, RSD= 2. 08%), The lowest detecting concentration was 0. 02 mg·L^-1. The intra-day and inter-day precision were both less than 10% and the low, middle and high extraction recoveries were more than 99% (n = 5). CONCLUSION The method is accurate, sensitive and suitable for the study of therapeutic drug monitoring for pioglitazone hydrochloride, especially combined with other medicines.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2008年第15期1262-1265,共4页 Chinese Journal of Hospital Pharmacy
关键词 盐酸吡格列酮 高效液相色谱法 血药浓度 pioglitazone hydrochloride HPLC plasma concentration
  • 相关文献

参考文献10

二级参考文献31

  • 1[1]Yamashita K, Murakami H, Okuda T, et al. High-performance liquid chromatographic determination of pioglitazone and its metabolites in human serum and urine[J]. J Chromatogr Biomed Appl, 1996,677:141-146.
  • 2[2]Zhong WZ, Williams MG. Simultaneous quantitation of pioglitazone and its metabolites in human serum by liquid chromatography and solid phase extraction[J]. J Pharm Biomed Anal, 1996, 14(4):465-473.
  • 3[3]Zhong WZ, Lakings DB. Determination of pioglitazone in dog serum using solid-phase extraction and high-performance liquid chromatographic with ultra-violet (229 nm) detection[J]. J Chromatogr Biomed Appl, 1989, 490:377-385.
  • 4Gillies PS, Dunn CJ. Pioglitazone[ J ]. Drugs ,2000,60(2) :333.
  • 5Yamashita K, Murakami H, Okuda T, et al. High-performance liquid chromatographic determination of pioglitazone and its metabolites in human serum and urine [ J ]. J Chromatogr B,1996,677:141.
  • 6ActosTM ( Pioglitazone Hydrochloride) Tablets. http://WWW.FDA. GOV.
  • 7Kiyota Y, Kondo T, Maeshiba Y, et al. Studies on the Metabolism of the antidiabetic agent pioglitazone, identification of metabolites in rats and dogs[J ]. Arzneim Forsch/Drug Res,1997,47( 1 ):22.
  • 8Maeshiba Y, Kiyota Y, Yamashita K, et al. Disposition of the antidiabetic agent pioglitazone in rats, dogs, and monkeys [ J].Arzneim Forsch/Drug Res, 1997,47( 1 ) : 29.
  • 9Gillies PS, Dunn CJ. Pioglitamne [ J ]. Drugs, 2000, 60 (2) :333.
  • 10Maeshiba Y, Kiyota Y, Yamashita K, et al. Disposition of the new antidiabetic agent pioglitazone in rots, dogs, and monkeys[J]. Arzneim Forsch/Drug Res, 1997, 47(1): 29.

共引文献33

同被引文献1960

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部